Benchling

Unlocking the power of biotech with modern software for modern science

San Francisco, United States · Founded 2012 · $476.5M raised

Employees
501–1000
Founded
2012
Business Model
B2B
Total Funding
$476.5M
Last Round
$100.0M Series G+Nov 2021
Rounds
11

About

Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, the materials we wear, and the household goods that we rely on every day. Biotech R&D is radically transforming our world, but to move at the new speed of science, scientists need better technology. Benchling’s mission is to unlock the power of biotechnology. The world’s biotech leaders and innovators use our R&D Cloud to power the development of breakthrough products and accelerate time to milestone and market.

Summary

Benchling is a Biotech company based in San Francisco, United States, founded in 2012. It has raised $476.5M in total across 11 rounds, most recently a $100.0M Series G+ round in Nov 2021. Investors include Benchmark, Andreessen Horowitz and Thrive Capital.

Tech & App Stack

17 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series G+Series G+Nov 2021
$100.0M

Sign up to see all 11 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies